Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression

source extracted confidence: high 2026-04-09
#major-depressive-disorder #docosahexaenoic-acids #eicosapentaenoic-acid #fatty-acids-omega-3 #humans

Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression

Hallahan et al., 2016 | Br J Psychiatry | Meta Analysis

Citation

Hallahan Brian, Ryan Timothy, ... Davis John M. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br J Psychiatry. 2016-Sep;209(3):192-201. doi:10.1192/bjp.bp.114.160242

Abstract

BACKGROUND: Trials evaluating efficacy of omega-3 highly unsaturated fatty acids (HUFAs) in major depressive disorder report discrepant findings. AIMS: To establish the reasons underlying inconsistent findings among randomised controlled trials (RCTs) of omega-3 HUFAs for depression and to assess implications for further trials. METHOD: A systematic bibliographic search of double-blind RCTs was conducted between January 1980 and July 2014 and an exploratory hypothesis-testing meta-analysis performed in 35 RCTs including 6665 participants receiving omega-3 HUFAs and 4373 participants receiving placebo. RESULTS: Among participants with diagnosed depression, eicosapentaenoic acid (EPA)-predominant formulations (>50% EPA) demonstrated clinical benefits compared with placebo (Hedge's G = 0.61, P<0.001) whereas docosahexaenoic acid (DHA)-predominant formulations (>50% DHA) did not. EPA failed to prevent depressive symptoms among populations not diagnosed for depression. CONCLUSIONS: Further RCTs should be conducted on study populations with diagnosed or clinically significant depression of adequate duration using EPA-predominant omega-3 HUFA formulations.

Key Findings

Among participants with diagnosed depression, eicosapentaenoic acid (EPA)-predominant formulations (>50% EPA) demonstrated clinical benefits compared with placebo (Hedge's G = 0.61, P<0.001) whereas docosahexaenoic acid (DHA)-predominant formulations (>50% DHA) did not. EPA failed to prevent depressive symptoms among populations not diagnosed for depression.

Outcomes Measured

  • depression

Population

Field Value
Population See abstract
Sample Size 6665
Age Range See abstract
Condition depression

MeSH Terms

  • Major Depressive Disorder
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid
  • Fatty Acids, Omega-3
  • Humans

Evidence Classification

  • Level: Meta Analysis
  • Publication Types: Journal Article, Meta-Analysis, Review, Research Support, N.I.H., Intramural
  • Vertical: omega-3

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09